In recent years, in silico analysis suggested that overexpression of the CDH16 gene, whose expression act as a biomarker for thyroid cancer, negatively regulates the AXIN1 expression in thyroid tissue.17 This evidence concerns the gene AXIN1 and thyroid gland carcinoma.